SciELO - Scientific Electronic Library Online

vol.15 issue4Detection of antiplatelet autoantibodies by ELISA in patients with autoimmune thrombocytopenic purpura author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO


Revista Archivo Médico de Camagüey

On-line version ISSN 1025-0255


GONZALEZ GONZALEZ, Félix et al. Intensive insulin treatment versus conventional of hyperglycemia in seriously ill patients. AMC [online]. 2011, vol.15, n.4, pp.642-652. ISSN 1025-0255.

Background: hyperglycemia in patients on critical condition is considered a sign of poor prognosis so it is necessary a strict glycaemic control, where the intensive insulin therapy is most commonly used. Objective: to propose a scheme of intensive insulin treatment for glycaemic control in seriously ill patients. Method: an observational prospective study was conducted in 240 patients admitted in the critically ill care service at the University Hospital Manuel Ascunce Domenech from June 2008 to September 2008, which represented the 22,3 % of the total of patients admitted in these units, 125 women and 115 men, the age group of 66 years and over prevailed. All patients presented two glycemia over 7, 8 mmol/l, in the first 12h of admission were included and according to the primary physician criterion, conventional or intensive hypoglycemic treatment was applied. Results: the intensive hypoglycemic treatment was used in 20 % of cases, reporting in a shortest time to achieve glycemic control. The hospital stay in this group was lower than 25 % in comparison with the group that received conventional treatment. Conclusions: intensive hypoglycemic treatment proved to be effective in seriously ill patients with hyperglycemia.


        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License